Literature DB >> 33926659

Lifespan Perspective on Congenital Heart Disease Research: JACC State-of-the-Art Review.

Gerhard-Paul Diller1, Alexandra Arvanitaki2, Alexander R Opotowsky3, Kathy Jenkins4, Philip Moons5, Alexander Kempny6, Animesh Tandon7, Andrew Redington8, Paul Khairy9, Seema Mital10, Michael Α Gatzoulis6, Yue Li11, Ariane Marelli12.   

Abstract

More than 90% of patients with congenital heart disease (CHD) are nowadays surviving to adulthood and adults account for over two-thirds of the contemporary CHD population in Western countries. Although outcomes are improved, surgery does not cure CHD. Decades of longitudinal observational data are currently motivating a paradigm shift toward a lifespan perspective and proactive approach to CHD care. The aim of this review is to operationalize these emerging concepts by presenting new constructs in CHD research. These concepts include long-term trajectories and a life course epidemiology framework. Focusing on a precision health, we propose to integrate our current knowledge on the genome, phenome, and environome across the CHD lifespan. We also summarize the potential of technology, especially machine learning, to facilitate longitudinal research by embracing big data and multicenter lifelong data collection.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  artificial intelligence; congenital heart disease; disease trajectories; lifespan; precision medicine; research

Year:  2021        PMID: 33926659     DOI: 10.1016/j.jacc.2021.03.012

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  8 in total

Review 1.  Changing epidemiology of congenital heart disease: effect on outcomes and quality of care in adults.

Authors:  Aihua Liu; Gerhard-Paul Diller; Philip Moons; Curt J Daniels; Kathy J Jenkins; Ariane Marelli
Journal:  Nat Rev Cardiol       Date:  2022-08-31       Impact factor: 49.421

2.  Single Ventricle and Valve-in-Valve, An Impediment or a New Horizon for TAVR?

Authors:  Ezequiel Munoz; Marco Barzallo; Marc Knepp; Kristi Ryan Apn; Juan Del Cid Fratti; Sudhir Mungee
Journal:  JACC Case Rep       Date:  2022-06-15

3.  Persistent Markers of Kidney Injury in Children Who Developed Acute Kidney Injury After Pediatric Cardiac Surgery: A Prospective Cohort Study.

Authors:  Jef Van den Eynde; Thomas Salaets; Jacoba J Louw; Jean Herman; Luc Breysem; Dirk Vlasselaers; Lars Desmet; Bart Meyns; Werner Budts; Marc Gewillig; Djalila Mekahli
Journal:  J Am Heart Assoc       Date:  2022-03-18       Impact factor: 6.106

4.  Multimodal MRI Analysis of Brain Metabolism in Maintenance Hemodialysis Patients Based on Cognitive Computing.

Authors:  Yan Zhang; Hui Ma; Xinguang Lv; Qinjun Han
Journal:  J Healthc Eng       Date:  2021-08-09       Impact factor: 2.682

5.  Early Thymectomy Is Associated With Long-Term Impairment of the Immune System: A Systematic Review.

Authors:  Nara Vasconcelos Cavalcanti; Patrícia Palmeira; Marcelo Biscegli Jatene; Mayra de Barros Dorna; Magda Carneiro-Sampaio
Journal:  Front Immunol       Date:  2021-11-25       Impact factor: 7.561

6.  Medicine-Based Evidence in Congenital Heart Disease: How Artificial Intelligence Can Guide Treatment Decisions for Individual Patients.

Authors:  Jef Van den Eynde; Cedric Manlhiot; Alexander Van De Bruaene; Gerhard-Paul Diller; Alejandro F Frangi; Werner Budts; Shelby Kutty
Journal:  Front Cardiovasc Med       Date:  2021-12-02

7.  A novel KLF13 mutation underlying congenital patent ductus arteriosus and ventricular septal defect, as well as bicuspid aortic valve.

Authors:  Pradhan Abhinav; Gao-Feng Zhang; Cui-Mei Zhao; Ying-Jia Xu; Juan Wang; Yi-Qing Yang
Journal:  Exp Ther Med       Date:  2022-03-01       Impact factor: 2.447

Review 8.  Congenital Heart Disease: The State-of-the-Art on Its Pharmacological Therapeutics.

Authors:  Carlos Daniel Varela-Chinchilla; Daniela Edith Sánchez-Mejía; Plinio A Trinidad-Calderón
Journal:  J Cardiovasc Dev Dis       Date:  2022-06-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.